Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma(†)

Convection-enhanced delivery (CED) of cintredekin besudotox (CB) was compared with Gliadel wafers (GW) in adult patients with glioblastoma multiforme (GBM) at first recurrence. Patients were randomized 2:1 to receive CB or GW. CB (0.5 µg/mL; total flow rate 0.75 mL/h) was administered over 96 hours...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kunwar, Sandeep, Chang, Susan, Westphal, Manfred, Vogelbaum, Michael, Sampson, John, Barnett, Gene, Shaffrey, Mark, Ram, Zvi, Piepmeier, Joseph, Prados, Michael, Croteau, David, Pedain, Christoph, Leland, Pamela, Husain, Syed R., Joshi, Bharat H., Puri, Raj K.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2010
Teme:
Clinical Investigations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2940677/
https://ncbi.nlm.nih.gov/pubmed/20511192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nop054
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items